CooperCompanies’ (NYSE:COO) CooperSurgical business has purchased Aegea Medical, nearly a year after Aegea secured FDA approval for its Mara water vapor ablation system for treating heavy menstrual bleeding.
The financial terms of the deal were not disclosed in the companies’ announcement yesterday.
The companies pointed out an international, multi-center pivotal clinical trial enrolling 155 women, in which 93% of women reported no to moderate bleeding after treatment with the Mara system. The two-minute, in-office Mara treatment ablates the lining of the uterus — the source of heavy menstrual bleeding among pre-menopause women.
“The Mara water vapor ablation system gives women a great option for a safe and convenient in-office procedure to help with what can often be a debilitating health issue,” CooperSurgical CEO Holly Sheffield said in a news release.